510(k) Report

FDA product code · Physical medicine

Stimulator, Muscle, Powered, For Muscle Conditioning

NGXClass II21 CFR 890.5850510(k) required163 decisions since 20012 recalls

163 FDA decisions since 2001. 510(k) reviews decided 2021–2025 took a median of 167 days (half between 72 and 280). 2 recalls name this code, 0 of them Class I. The most-cited predicate is K011880, named by 12 later devices.

A powered muscle stimulator for muscle conditioning is a device used for other than medical purposes to apply an electrical current to electrodes on a person's skin to temporarily affect the stimulated muscle's contractile properties, force output, and/or fatigue resistance. Unlike the classified Powered Muscle Stimulator devices intended for use in physical medicine and rehabilitation, this device is not intended…

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, physical medicine panel

Twenty years of NGX at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · NGX

15in 2025

2007: 72008: 32009: 42010: 62011: 52012: 32013: 62014: 62015: 92016: 42017: 102018: 62019: 142020: 112021: 122022: 62023: 122024: 122025: 152026 (partial year): 4
2007high 15 (2025) · low 3 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NGX

93in 2025

2007: 135 days median2008: 209 days median2009: 132 days median2010: 180 days median2011: 291 days median2012: 362 days median2013: 269 days median2014: 298 days median2015: 184 days median2016: 240 days median2017: 108 days median2018: 104 days median2019: 167 days median2020: 207 days median2021: 256 days median2022: 307 days median2023: 96 days median2024: 207 days median2025: 93 days median2026 (partial year): 118 days median
2007high 362 (2012) · low 93 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NGX

2in 2013

2013: 2
2007high 2 (2013) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NGX

15in 2025

2011: 12013: 12015: 72016: 212017: 22018: 62019: 42020: 72021: 52022: 72023: 82024: 112025: 15
2007high 21 (2016) · low 0 (2007)2025

MAUDE reports naming product code NGX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007713500
2008320900
2009413200
2010618000
2011529101
2012336200
2013626921
2014629800
2015918407
20164240021
20171010802
2018610406
20191416704
20201120707
20211225605
2022630707
2023129608
202412207011
20251593015
202641180—
FIG. 1 — NGX by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in NGX? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Related product codes

Other codes under 21 CFR 890.5850.